For Healthcare Providers

Affordable, Sustainable Risk Reduction

Comprehensive GLP-1 weight loss programs designed to support your patients' health goals

GLP-1 + Cardiovascular Care for Heart Health

For your overweight CVD patients, we offer an affordable, customized GLP-1/nutrition focus to complement long-term management and prevention care.

Significant Weight Loss

GLP-1 agonists can achieve 10-20% safe and durable weight loss - directly impacting cardiometabolic health. We customize care to make it a safe, sustainable, affordable option.

Pleiotropic Synergies

While statins stabilize plaques, GLP-1s address contributing metabolic and inflammatory drivers of progressive cardiovascular disease. We focus on nutrient-dense diet changes to reduce glycation, insulin resistance, and dyslipidemia.

CV Risk Reduction

Trials show GLP-1 agonists reduce MACE by 12-26% beyond the reductions of background statin therapy. This effect is seen in both diabetic and non-diabetic CVD patients.

Consider SWL for affordable GLP-1 therapy and nutritional guidance. You can provide your obese CVD patients a plan to lower cardiovascular risk, beyond what statins alone can achieve.

Weight Loss

Affordable, sustained care and progressive nutritional guidance are key. We monitor and interact with patients' weight loss journey continuously.

Integrated Care

SWL is not a primary care offering - we focus only on safe, affordable, integrated GLP-1 care and prescribing. CVD Patients from any practice seeking GLP-1 care are welcome.

Customized Care

CV risk reduction needs a durable plan. Our costs are budget-friendly, and care is customized to minimize negative side effects while evolving dietary changes - supported by GLP-1 care - as the primary component for long-term success.

Communication

We monitor and interact with patients' weight loss journey continuously. Weekly logging of effects, side effects, and weight-loss trend is collected. Summaries are provided to patients and specialist/primary care providers.

Pre-operative Weight Loss

Reducing weight to pre-operative goals

Affordable, achievable weight loss to reduce surgery risks and improve outcomes

For your overweight patients that need weight loss as part of operative and recovery planning, we offer affordable, goal directed, customized GLP-1 care focused on fat loss, lean-mass preservation, and improved health status.

1. Achievable Weight Loss

GLP-1 agonists enable 10-20% safe, progressive weight loss with guided care - reducing surgical risks. Tailored plans ensure an efficient, achievable, and cost-effective path to weight goals.

2. Metabolic Improvement

We focus on diet and nutrient improvements with customized GLP-1 care that reduces glycemic problems and improves metabolic balance. Nutrient dense eating and reduced appetite with GLP-1 care facilitate weight loss and improve pre-operative health status.

3. Sustainable

Affordable GLP-1 care offers obese patients a plan for long-term weight loss to goal and beyond.

Weight Loss

Affordable, sustained care and progressive nutritional guidance are key. We monitor and interact with patients' weight loss journey continuously.

Integrated Care

SWL is not a primary care offering - we focus only on safe, affordable, integrated GLP-1 care and prescribing. Patients from any practice seeking GLP-1 care are welcome.

Customized Care

Surgical reduction needs a long-term timeline plan. Our costs are budget-friendly, and care is customized to minimize negative side effects while achieving substantial weight loss in most patients.

Communication

We monitor and interact with patients' weight loss journey continuously. Weekly logging of effects, side effects, and weight-loss trend is collected. Summaries are provided to patients and providers.

Frequently Asked Questions

How to get started

Have questions about our programs? We're here to help you understand how our GLP-1 weight loss programs can benefit your patients.

Ask Questions

Cost of Care

All care is cash/credit card pay. We do not accept or bill insurance. FSA/HSA plans are accepted.